Decreasing Narcotics in Advanced Pelvic Surgery

NCT02110719 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2016-08-17

No results posted yet for this study

Summary

In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-operative recovery, and expedite return to baseline functional status. Pathways often are developed by a team of surgeons, nurses, pain specialists, anesthesiologists and other support staff. Postoperative components often involve multi-modal analgesia, early return to activity and early return to a regular diet. The goal of this study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery with a primary goal of decreasing narcotic usage.

Conditions

Interventions

DRUG

Celebrex

DRUG

Gabapentin

DRUG

IV acetaminophen

DRUG

oral acetaminophen

DRUG

oral ibuprofen

DRUG

percocet

DRUG

vicodin

DRUG

Oxycodone

DRUG

dilaudid

DRUG

zofran

Sponsors & Collaborators

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Krista Reagan, MD · Hartford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-07-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110719 on ClinicalTrials.gov